<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03129295</url>
  </required_header>
  <id_info>
    <org_study_id>MPC-SHRC-002</org_study_id>
    <nct_id>NCT03129295</nct_id>
  </id_info>
  <brief_title>Phase II Proof of Concept Study in Uncomplicated UTI</brief_title>
  <official_title>A Randomized, Double-Blind, Placebo-Controlled, MultiCenter Study of the Efficacy and Safety of MPC-SHRC for the Relief of Symptoms Associated With Uncomplicated Urinary Tract Infections</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mission Pharmacal</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mission Pharmacal</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A study of the efficacy and safety of MPC-SHRC for the relief of symptoms associated with
      uncomplicated urinary tract infections.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2017</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change from baseline on assessment instrument</measure>
    <time_frame>6 hours after the first dose of study drug</time_frame>
    <description>Patient reported outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on assessment instruments</measure>
    <time_frame>Three hour intervals after first dose of study drug</time_frame>
    <description>Patient reported outcome</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change from baseline on Pain Scale</measure>
    <time_frame>Three hour intervals after first dose of study drug</time_frame>
    <description>Patient reported outcome</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Urinary Tract Infections</condition>
  <arm_group>
    <arm_group_label>MPC-SHRC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>oral tablet four times a day for 3 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>oral tablet four times a day for 3 days</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>MPC-SHRC</intervention_name>
    <description>Oral tablet four times a day for 3 days</description>
    <arm_group_label>MPC-SHRC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo Oral Tablet</intervention_name>
    <description>Oral tablet four times a day for 3 days</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Non-pregnant, nonlactating woman with moderate to severe symptoms of urinary tract
             infection

          -  On adequate birth control

          -  Normal ECG

        Exclusion Criteria:

          -  Participated in any other trial within 30 days of visit 1

          -  Known or suspected allergy to investigational drug

          -  Narrow angle glaucoma

          -  Recovering from chicken pox or flu-like symptoms

          -  History of peptic ulcer, gastrointestinal bleeding, gastrointestinal surgery, or
             gastrointestinal dysfunction which could interfere with drug absorption

          -  Taken any drugs for within past 24 hours for symptoms associated with uncomplicated
             urinary tract infections

          -  Currently taking prohibited drugs

          -  Taken an antibiotic within 7 days of Visit 1

          -  Are ineligible to receive an antibiotic

          -  History of urinary retention

          -  History of interstitial cystitis

          -  History of impaired renal function

          -  History of impaired hepatic function

          -  Diagnosis or suspicion of complicated urinary tract infection or systemic infection

          -  History of substance abuse
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Margaret E. Hurley, MD</last_name>
    <role>Study Director</role>
    <affiliation>Hurley Consulting Associates Ltd.</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Hurley Consulting Associates</last_name>
    <phone>1-908-273-8490</phone>
    <email>info@hurleyconsulting.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>First Urology PSC</name>
      <address>
        <city>Jeffersonville</city>
        <state>Indiana</state>
        <zip>47130</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Beyer Research</name>
      <address>
        <city>Kalamazoo</city>
        <state>Michigan</state>
        <zip>49009</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Lawrence OB/GYN Clinical Research, LLC</name>
      <address>
        <city>Lawrenceville</city>
        <state>New Jersey</state>
        <zip>08648</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Women's Health Research Center</name>
      <address>
        <city>Plainsboro</city>
        <state>New Jersey</state>
        <zip>08536</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 19, 2017</study_first_submitted>
  <study_first_submitted_qc>April 21, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2017</study_first_posted>
  <last_update_submitted>April 21, 2017</last_update_submitted>
  <last_update_submitted_qc>April 21, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infection</mesh_term>
    <mesh_term>Urinary Tract Infections</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

